Amplity Study Presented at ISPOR Europe 2024 Highlights Trends in GLP-1 Receptor Agonist Medication Use in U.S. Patients
Amplity’s AskX, An AI-Driven Search Tool, Named One Of The Most Interesting Innovations Of 2023 By PM360
Amplity’s Breakthrough AI-driven Platform Offers Pharma Leaders Actionable Intel During Crucial Drug Launch Window
Amplity Study Identifies Major Gaps In Biomarker Testing & Targeted Therapy Use In Non-Small Cell Lung Cancer In The U.S.